Molecular Mechanisms of Zebrafish Heart Regeneration
斑马鱼心脏再生的分子机制
基本信息
- 批准号:8078575
- 负责人:
- 金额:$ 3.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultBlood VesselsCardiacCardiac MyocytesCell ProliferationCellsCicatrixCoronaryCoronary VesselsDNA biosynthesisDefectDegenerative DisorderDevelopmentDominant-Negative MutationEmbryoEndothelial CellsEpicardiumExcisionFailureFishesFunctional disorderFutureGoalsHealedHeartHeart DiseasesHeat-Shock ResponseHumanIn VitroInjuryLeadMammalsMediatingMesenchymalModelingMolecularMyocardialMyocardiumNatural regenerationOperative Surgical ProceduresOrganOrganismPDGFRA genePDGFRB genePathologyPericytesPlatelet-Derived Growth FactorPlatelet-Derived Growth Factor ReceptorProcessReceptor SignalingRegenerative MedicineResearchSignal TransductionSystemTestingTherapeuticTimeTissuesTransgenic OrganismsUnited StatesZebrafishbasecell typedesigndisabilityepithelial to mesenchymal transitionhealingimprovedin vivoknock-downmortalityneovascularizationnovel therapeutic interventionprogenitorpromoterpublic health relevanceregenerativetissue regeneration
项目摘要
DESCRIPTION (provided by applicant): Heart disease is among the leading causes of disability and mortality in United States and worldwide. After ischemic injury, human hearts cannot regenerate and heal by scarring, which gradually leads to cardiac dysfunction. Replacing the damaged myocardium with new cardiomyocytes and neovascularization may restore cardiac function. By contrast to mammals, zebrafish hearts have remarkable regenerative capacity, completely regenerating lost tissue after surgical resection. Very little is known about the molecular and cellular mechanisms of heart regeneration in zebrafish. During this process, embryonic epicardial and pericyte/mesenchymal markers are upregulated, suggesting that the epicardium is activated and undergoes an epithelial-to-mesenchymal transition (EMT) to form new blood vessels. We found platelet-derived growth factors (PDGFs) are important for heart regeneration. Blocking PDGF signaling caused impaired new blood vessel formation and decreased DNA synthesis in cardiomyocytes during zebrafish heart regeneration. We hypothesize that PDGF signaling is required for epicardial cell proliferation, epicardial EMT, and cardiomyocyte proliferation. We propose to characterize the functions of PDGFR2 signaling in epicardial cell proliferation, EMT, and new blood vessel formation in vivo (Aim 1) and in vitro (Aim 2). We further propose to determine the function of PDGFR1 signaling in zebrafish cardiomyocytes and cardiac progenitors (Aim 3). Our unique zebrafish heart regeneration model and parallel in vitro and in vivo approaches will allow us to determine the molecular and cellular mechanisms of zebrafish heart regeneration. Our long-term goal is the development of novel therapeutic approaches for heart diseases in the future.
PUBLIC HEALTH RELEVANCE: Regenerative medicine holds a great deal of promise for treating congenital and degenerative diseases. The goal of this proposal is to determine the molecular and cellular mechanisms of heart regeneration in zebrafish, an organism with a natural regenerative ability. We expect the proposed research can lead to findings that may enhance regenerative capacity in diseased human hearts in the future.
描述(由申请人提供):心脏病是美国和全球残疾和死亡率的主要原因之一。缺血性损伤后,人心无法通过疤痕再生和愈合,这逐渐导致心脏功能障碍。用新的心肌细胞和新血管造成损害的心肌替换可能恢复心脏功能。与哺乳动物相比,斑马鱼的心脏具有显着的再生能力,在手术切除后完全再生组织的再生。关于斑马鱼心脏再生的分子和细胞机制知之甚少。在此过程中,胚胎性心外膜和周环/间充质标记被上调,表明心外膜被激活,并经历上皮 - 间质转变(EMT)以形成新的血管。我们发现血小板衍生的生长因子(PDGF)对于心脏再生很重要。阻断PDGF信号导致斑马鱼心脏再生期间心肌细胞中新血管的形成受损和DNA合成降低。我们假设PDGF信号传导是心外膜细胞增殖,心外膜EMT和心肌细胞增殖所必需的。我们建议表征PDGFR2信号传导在体内(AIM 1)和体外(AIM 2)中的心外膜细胞增殖,EMT和新血管形成的功能。我们进一步建议确定斑马鱼心肌细胞和心脏祖细胞中PDGFR1信号的功能(AIM 3)。我们独特的斑马鱼心脏再生模型以及体外和体内方法平行的方法将使我们能够确定斑马鱼心脏再生的分子和细胞机制。我们的长期目标是将来开发新型心脏病治疗方法。
公共卫生相关性:再生医学对治疗先天性和退化性疾病有很大的希望。该提案的目的是确定斑马鱼(一种具有自然再生能力的生物体)心脏再生的分子和细胞机制。我们预计拟议的研究可能会导致发现,这些发现可能会增强未来患病人类心脏的再生能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ching-Ling E Lien其他文献
Ching-Ling E Lien的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ching-Ling E Lien', 18)}}的其他基金
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10513736 - 财政年份:2022
- 资助金额:
$ 3.61万 - 项目类别:
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10627211 - 财政年份:2022
- 资助金额:
$ 3.61万 - 项目类别:
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10053252 - 财政年份:2020
- 资助金额:
$ 3.61万 - 项目类别:
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10460242 - 财政年份:2020
- 资助金额:
$ 3.61万 - 项目类别:
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10249328 - 财政年份:2020
- 资助金额:
$ 3.61万 - 项目类别:
Cardiac lymphatic vessels in heart development and regeneration.
心脏淋巴管在心脏发育和再生中的作用。
- 批准号:
10683731 - 财政年份:2020
- 资助金额:
$ 3.61万 - 项目类别:
Cxc12 chemokine signaling regulates synchronous development of coronary vessels and myocardium
Cxc12趋化因子信号调节冠状血管和心肌的同步发育
- 批准号:
9239945 - 财政年份:2017
- 资助金额:
$ 3.61万 - 项目类别:
相似国自然基金
基于线粒体能量代谢及微循环障碍的多参数MR诊断和预测心脏移植物血管病研究
- 批准号:82371903
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
心脏微血管内皮细胞来源的MYDGF调控CD248保护心梗后心肌的机制研究
- 批准号:82370294
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cav1/Nrf2/Hmox1通路调节糖尿病心脏微血管内皮细胞铁死亡减轻心肌缺血再灌注损伤的机制研究
- 批准号:82300492
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
适当冷暴露抑制心脏成纤维细胞Sfrp2甲基化修饰调控心肌梗死后血管新生的研究
- 批准号:82300280
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于机器学习的心脏大血管手术后谵妄预测模型研究
- 批准号:82372217
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
- 批准号:
10733384 - 财政年份:2023
- 资助金额:
$ 3.61万 - 项目类别:
Investigation of Sex and Gender Differences in Cardiovascular Risk in Rural Communities
农村社区心血管风险的性别和性别差异调查
- 批准号:
10608716 - 财政年份:2023
- 资助金额:
$ 3.61万 - 项目类别:
Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
- 批准号:
10584768 - 财政年份:2023
- 资助金额:
$ 3.61万 - 项目类别:
Cell therapy regulates cardiac healing through innate immune response
细胞疗法通过先天免疫反应调节心脏愈合
- 批准号:
10561163 - 财政年份:2023
- 资助金额:
$ 3.61万 - 项目类别:
Novel patient biomarkers and mechanisms of TKI associated Cardiotoxicity
TKI 相关心脏毒性的新型患者生物标志物和机制
- 批准号:
10728954 - 财政年份:2023
- 资助金额:
$ 3.61万 - 项目类别: